Semi-vioxanthin isolated from marine-derived fungus regulates tumor necrosis factor-α, cluster of differentiation (CD) 80, CD86, and major histocompatibility complex class 2 expression in RAW264.7 cells via nuclear factor-κB and mitogen-activated protein kinase signaling pathways
-
- Yang Xin-Ying
- Department of Infection Biology, Zoonosis Research Center, Wonkwang University School of Medicine
-
- Cai Sheng-Xin
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, Institute of Marine Drugs and Food, Ocean University of China
-
- Zhang Wen-Ji
- Department of Infection Biology, Zoonosis Research Center, Wonkwang University School of Medicine
-
- Tang Xue-Lian
- Department of Infection Biology, Zoonosis Research Center, Wonkwang University School of Medicine
-
- Shin Hye-Young
- Department of Infection Biology, Zoonosis Research Center, Wonkwang University School of Medicine
-
- Lee Joo-Young
- Department of Life Science, Gwangju Institute of Science and Technology
-
- Gu Qian-Qun
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, Institute of Marine Drugs and Food, Ocean University of China
-
- Park Hyun
- Department of Infection Biology, Zoonosis Research Center, Wonkwang University School of Medicine
書誌事項
- タイトル別名
-
- Semi-vioxanthin Isolated from Marine-Derived Fungus Regulates Tumor Necrosis Factor-.ALPHA., Cluster of Differentiation (CD) 80, CD86, and Major Histocompatibility Complex Class II Expression in RAW264.7 Cells via Nuclear Factor-.KAPPA.B and Mitogen-Activated Protein Kinase Signaling Pathways
- Semi vioxanthin isolated from marine derived fungus regulates tumor necrosis factor a cluster of differentiation CD 80 CD86 and major histocompatibility complex class 2 expression in RAW264 7 cells via nuclear factor kB and mitogen activated protein kinase signaling pathways
この論文をさがす
説明
Semi-vioxanthin isolated from marine-derived fungus was assessed for immunoregulatory activity in mouse RAW264.7 macrophages. In the present study, the facilitative effects of semi-vioxanthin on tumor necrosis factor-α (TNF-α) and its mRNA expression and on expression of the co-stimulatory molecules, cluster of differentiation (CD) 80, CD86 and major histocompatibility complex class II (MHC II), as well as the molecular mechanism underlying the immunologic enhancement properties of semi-vioxanthin were studied. Our results clearly indicated that semi-vioxanthin treatment resulted in the degradation of IκBα, which led to the activation and nuclear translocation of the p65 subunit of nuclear factor-κB (NF-κB), as determined by immunoblotting, immunofluorescence and electrophoretic mobility shift assays (EMSA). Moreover, TNF-α production was prevented by NF-κB and mitogen-activated protein kinase (MAPK) inhibitors. Inhibition of NF-κB and extracellular signal regulated kinases (ERK1/2) activity by specific inhibitors blunted the effect of semi-vioxanthin on the up-regulation of CD80, CD86 and MHCII expression, but neither p38 MAPK nor c-Jun N-terminal kinase (JNK) inhibitor had this effect. Thus, we demonstrate that semi-vioxanthin regulates TNF-α production through NF-κB and MAPK signaling pathways. Activation of NF-κB and ERK1/2 were necessary for CD80, CD86 and MHCII expression induced by semi-vioxanthin. These data suggest that semi-vioxanthin has immunoregulatory effects.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 31 (12), 2228-2233, 2008
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204626576256
-
- NII論文ID
- 110007005020
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 9715930
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可